z-logo
open-access-imgOpen Access
A Comparative Study of Single Dose Dexamethasone versus Ondansetron for control of Post Operative Nausea and Vomiting after High-Risk Surgeries
Author(s) -
Ashwin Joginipally,
Nikhil Mudgalkar
Publication year - 2020
Publication title -
perspectives in medical research
Language(s) - English
Resource type - Journals
eISSN - 2348-229X
pISSN - 2348-1447
DOI - 10.47799/0801.13
Subject(s) - ondansetron , nausea , medicine , vomiting , dexamethasone , anesthesia , postoperative nausea and vomiting , surgery
The occurrence of postoperative nausea andvomiting is generally associated with anesthesia and surgery.The problem is compounded in cases of high-risk surgerieswhere the incidence is quite high. The present study wasdesigned to compare the efficacy of Dexamethasone andOndansetron. Methods: This study was undertaken at thePrathima Institute of Medical Sciences, Naganoor, Karimnagar.In this randomized, open clinical trial, we studied 80 ASA gradesI to 1V patients of age group 20-60 years undergoingLaparoscopic Laparotomy, Major Gynecological surgeries,Renal, Shoulder and ENT surgeries under general anesthesia.The patients were randomly divided into two groups, Group Iand Group II, each consisting of 80 patients. Group I received4mg dexamethasone intravenous (IV) just after intubation andgroup II received 4mg Ondansetron intravenous (IV), just beforeextubation. Results: The most common age group was 50 – 59years which had n=45(28.1%) patients out of which group Iwas n=24(15%) patients and n=21(13.1%) patients. The nextcommon age group was 20 – 29 years out of which n=23(14.4%) and n=18(11.2%). ondansetron group, early nausea ismild in 6.9%, moderate in 3.8%, and severe in 1.2% of patients.Whereas in the dexamethasone group early nausea is mild in6.2%, moderate in 4.4%, severe in 1.9% of patients. In theondansetron group, late nausea is mild in 9.4%, moderate in3.8%, and severe in 0.6% of patients. Whereas in thedexamethasone group late nausea is mild in 7.5%, moderatein 4.4%, severe in 0.6% of patients. In the ondansetron group,early vomiting is mild in 5.0%, moderate in 0.6%, and severe in0.6% of patients. Whereas in the dexamethasone group earlyvomiting is mild in 4.4%, moderate in 1.2%, severe in 0.6% ofpatients. Conclusion: dexamethasone given intravenously justafter intubation and ondansetron given intravenously justbefore extubation are safe and have similar efficacy in postoperative nausea and vomiting after elective surgeries undergeneral anesthesia having a high risk of PONV

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom